Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

BAY 43-9006

A drug used to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and thyroid cancer. It is also being studied in the treatment of other types of cancer. BAY 43-9006 blocks certain proteins, which may help keep cancer cells from growing and dividing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. BAY 43-9006 is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called Nexavar and sorafenib tosylate.
More Information
Search NCI's Dictionary of Cancer Terms